News Alert

ASAP 340B-Backed Bill Introduced in House

Capitol building
Key House Republicans on Tuesday introduced long-awaited—and contentious—legislation to overhaul the 340B program.
Key House Republicans on Tuesday introduced long-awaited—and contentious—legislation to overhaul the 340B program based on recommendations from a nonprofit group [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

340B Hospitals Prescribe Part D Drugs to a Much Higher Share of Vulnerable Populations, Says Hospital-Backed Report

A hospital-funded study found 340B hospitals prescribe a higher share of Medicare Part D drugs to a higher share of vulnerable patients.
Medicare Part D beneficiaries who received retail and specialty drugs from prescribers at 340B disproportionate share hospitals (DSH) were more [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Ohio Senator Introduces 340B Contract Pharmacy Access Bill in State Legislature

Ohio state Sen. Bob Hackett (R) introduced a bill to bar drugmaker 340B contract pharmacy restrictions in the state.
Ohio is the latest state to consider proposed legislation that would ban drugmakers from restricting covered entities’ acquisition of 340B [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Breaking News

Kansas Governor Rejects Provision to Delay New 340B Contract Pharmacy Protections

Kansas Gov. Laura Kelly (D) vetoed provisions of a bill that would have delayed a 340B contract pharmacy access law from taking effect.
A Kansas law that prohibits drugmaker 340B contract pharmacy restrictions is set to take effect July 1, as result of [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

340B Sales Increased 17% to $124B in 2023, Drug Industry Consulting Firm Finds 

Analysts from IQVIA found that 340B wholesale acquisition cost sales increased by 17% from 2022 to 2023.
The 340B program continued to expand in 2023, exceeding $124 billion in wholesale acquisition cost (WAC) sales—up from $107 billion [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

NC Treasurer Report Suggests 340B Hospitals Overcharged State Health Plan, Hospitals Pan the Findings

A report from N.C. Treasurer Dale Folwell found some hospitals are using 340B “to enrich themselves rather than to serve vulnerable communities.”
North Carolina hospitals that participate in the 340B program routinely overcharged cancer patients, taxpayers and state employees for oncology drugs, [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

340B Hospital Groups Ask MedPAC to Oppose Part B Rate Cut

Jonathan Jaffery, chief health care officer for AAMC, said reduced Medicare reimbursement to 340B hospitals would “devastate an already fragile health care safety net.”
Groups representing hospitals that rely on the 340B program recently urged congressional advisers against recommending reduced Medicare reimbursement to 340B [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Study Finds Newer 340B Public Hospitals More Likely to Increase Unprofitable Service Lines Than Newer Non-Profit Hospitals

Government-owned 340B hospitals recently enrolled in 340B were more likely to increase unprofitable services than new 340B nonprofit hospitals, a recent study found.
While newly enrolled 340B hospital entrants served higher numbers of Medicaid and rural patients than non-340B hospitals, government-owned 340B hospitals [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

News Alert

Novo to Extend Contract Pharmacy Restrictions to Grantees But Allow Them to Keep Access Under Conditions; Company Also Modifies Hospital Policy

Pharmaceutical manufacturer Novo Nordisk recently announced it will extend its 340B contract pharmacy restrictions to federal grantees.
Drugmaker Novo Nordisk this week announced that its contract pharmacy restrictions will soon apply to all grantee covered entities—not just [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

340B Program Critics, Supporters Target States 

ALEC, a conservative legislative group that receives drug industry funding, is advocating against state 340B legislation. Provider groups have criticized the campaign and launched their own efforts in support of 340B state bills.
As 340B stakeholders continue to hold out for long-awaited congressional action that could overhaul the discount drug pricing program, some [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
×

*Sign up for news summaries and alerts from 340B Report

Site Footer Live